Patient-Reported Outcomes as End Points in Nephrology Trials: Designing the Right Trial for the Right Question.
作者信息
Lavenburg Linda-Marie Ustaris, Jhamb Manisha
机构信息
Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
出版信息
J Am Soc Nephrol. 2024 Jul 1;35(7):952-954. doi: 10.1681/ASN.0000000000000389. Epub 2024 Apr 30.
Abstract
摘要
相似文献
1
Patient-Reported Outcomes as End Points in Nephrology Trials: Designing the Right Trial for the Right Question.患者报告结局作为肾脏病学试验的终点：针对正确问题设计恰当试验
J Am Soc Nephrol. 2024 Jul 1;35(7):952-954. doi: 10.1681/ASN.0000000000000389. Epub 2024 Apr 30.
2
SCORE-IT (Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes): a systematic review of registered trials.SCORE-IT（2型糖尿病随机有效性试验核心结局的选择）：已注册试验的系统评价
Trials. 2017 Dec 15;18(1):597. doi: 10.1186/s13063-017-2317-5.
3
Outcome Reporting in Cardiac Surgery Trials: Systematic Review and Critical Appraisal.心脏外科手术试验中的结果报告：系统评价与批判性评估
J Am Heart Assoc. 2015 Aug 17;4(8):e002204. doi: 10.1161/JAHA.115.002204.
4
Design and endpoints of clinical trials in hepatocellular carcinoma.肝细胞癌临床试验的设计与终点
J Natl Cancer Inst. 2008 May 21;100(10):698-711. doi: 10.1093/jnci/djn134. Epub 2008 May 13.
5
Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease.慢性肾脏病多种治疗时代未来肾脏保护试验的设计考量
Nephrol Dial Transplant. 2025 Feb 5;40(Supplement_1):i70-i79. doi: 10.1093/ndt/gfae210.
6
Outcomes in randomised controlled trials in prevention and management of carious lesions: a systematic review.预防和管理龋损的随机对照试验结果：一项系统评价
Trials. 2017 Nov 2;18(1):515. doi: 10.1186/s13063-017-2256-1.
7
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.开发C3肾小球病的治疗方法：肾脏健康倡议C3肾小球病试验终点工作组报告
Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1201-1208. doi: 10.2215/CJN.0000000000000505. Epub 2024 Jun 3.
8
Use of kidney function end points in kidney transplant trials: a systematic review.在肾移植试验中使用肾功能终点：系统评价。
Am J Kidney Dis. 2010 Dec;56(6):1140-57. doi: 10.1053/j.ajkd.2010.08.015. Epub 2010 Oct 30.
9
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.旨在实现慢性乙型肝炎和丁型肝炎治愈的临床试验治疗终点和研究设计指南：2022 年美国肝病研究学会-欧洲肝脏研究学会乙型肝炎-丁型肝炎治疗终点会议报告。
J Hepatol. 2023 Nov;79(5):1254-1269. doi: 10.1016/j.jhep.2023.06.002. Epub 2023 Jun 21.
10
A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology.呼吁在心脏电生理学中使用替代终点的试验实现透明化、改进报告及解读。
Heart Rhythm. 2025 Aug;22(8):e492-e499. doi: 10.1016/j.hrthm.2025.02.038. Epub 2025 Feb 26.
本文引用的文献
1
The design and baseline characteristics for the HOPE Consortium Trial to reduce pain and opioid use in hemodialysis.HOPE 联盟试验的设计和基线特征旨在减轻血液透析患者的疼痛和阿片类药物使用。
Contemp Clin Trials. 2024 Jan;136:107409. doi: 10.1016/j.cct.2023.107409. Epub 2023 Dec 10.
2
Effects of Technology Assisted Stepped Collaborative Care Intervention to Improve Symptoms in Patients Undergoing Hemodialysis: The TĀCcare Randomized Clinical Trial.技术辅助阶梯式协作护理干预对改善血液透析患者症状的影响：TĀCcare 随机临床试验。
JAMA Intern Med. 2023 Aug 1;183(8):795-805. doi: 10.1001/jamainternmed.2023.2215.
3
Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.管理维持性透析相关的症状负担：来自肾脏病：改善全球预后（KDIGO）争议会议的结论。
Kidney Int. 2023 Sep;104(3):441-454. doi: 10.1016/j.kint.2023.05.019. Epub 2023 Jun 7.
4
The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis.症状监测与反馈试验（SWIFT）：基于登记的血液透析中心随机对照试验方案。
Trials. 2022 May 19;23(1):419. doi: 10.1186/s13063-022-06355-0.
5
Validation of a Core Patient-Reported Outcome Measure for Fatigue in Patients Receiving Hemodialysis: The SONG-HD Fatigue Instrument.验证用于接受血液透析患者疲劳的核心患者报告结局测量工具：SONG-HD 疲劳量表。
Clin J Am Soc Nephrol. 2020 Nov 6;15(11):1614-1621. doi: 10.2215/CJN.05880420. Epub 2020 Oct 22.
6
Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.维持性血液透析患者抑郁症治疗的疗效比较：一项随机临床试验。
Ann Intern Med. 2019 Mar 19;170(6):369-379. doi: 10.7326/M18-2229. Epub 2019 Feb 26.
7
Fostering Innovation in Symptom Management among Hemodialysis Patients: Paths Forward for Insomnia, Muscle Cramps, and Fatigue.促进血液透析患者症状管理中的创新：针对失眠、肌肉痉挛和疲劳的前进之路。
Clin J Am Soc Nephrol. 2019 Jan 7;14(1):150-160. doi: 10.2215/CJN.07670618. Epub 2018 Nov 5.
8
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.患者报告结局纳入临床试验方案指南：SPIRIT-PRO 扩展
JAMA. 2018 Feb 6;319(5):483-494. doi: 10.1001/jama.2017.21903.
9
Patient-Reported Outcome Measures for Fatigue in Patients on Hemodialysis: A Systematic Review.透析患者疲劳的患者报告结局测量：系统评价。
Am J Kidney Dis. 2018 Mar;71(3):327-343. doi: 10.1053/j.ajkd.2017.08.019. Epub 2017 Dec 1.
Zotero 插件